May 2022 • PharmaTimes Magazine • 3
It’s fair to say that certain aspects of our industry have taken a while to change – in some cases several centuries! Notably among these are public image, internal demographics, understanding the totality of ‘end users’ and, more recently, cyber adaptation.
Perhaps all these roads lead to the all-encompassing digital zeitgeist, which pharma has gradually and, in the past few years, rapidly seized. Indeed, through modern connectivity the ultra-modern ‘patient 2.0’ has risen, the gravitas of gender parity has been profoundly highlighted and the majesty of difference has become undeniable.
Caricatures are difficult to alter but our industry is making progress and, as a result, its bedrock of life sciences advancement is also finding new gears. To paraphrase; ‘very little can happen in the fields of equality, diversity, inclusion and patient engagement for centuries and then decades can unfold in a couple of years’.
Getting closer to the very people we serve, and breaking bread with them as equals, while also making them stakeholders in the development of therapies is, in many ways, the promised land. It engenders trust, provides the touchpaper for transparency, reboots clinical trial design and, mercifully, encourages cross-sector collaborations with the NHS.
This recalibrating of the pharmaverse, and everyone’s place in it, is truly fascinating and many of the features in this month’s PharmaTimes orbit around it.
From a purely selfish point of view, these complex relationships also make my job much more interesting. Enjoy the magazine,
John Pinching
editor
PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com
Twitter: @PharmaTimes
EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Luci Sargood / business manager
luci.sargood@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2022 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.